Rachel Sprague
Pediatrics · Oklahoma City, OKNPI 1134773567
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,673 of the $4,443 with a category attached, or 82.7%. 30 manufacturers reported payments, led by Livanova USA, Inc. at 32.0% of the total. Reporting peaked in 2023 at $2,088 and has fallen 67.2% since, to $685 in 2025. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 173 payments — averaging $25.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$1K
- UCB, Inc.$730
- Neurelis, Inc.$345
- Immedica Pharma US, Inc.$300
- AbbVie$226
- Jazz Pharmaceuticals Inc.$156
- plus $1K from 24 others
What the payments were for
- Travel & lodging$77117%
- Food & beverage$3,67383%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 13 | $1,422 |
| UCB, Inc. | 38 | $730 |
| Neurelis, Inc. | 17 | $345 |
| Immedica Pharma US, Inc. | 10 | $300 |
| AbbVie | 11 | $226 |
| Jazz Pharmaceuticals Inc. | 8 | $156 |
| Eisai Inc. | 8 | $149 |
| Acadia Pharmaceuticals Inc | 7 | $144 |
| Catalyst Pharmaceuticals, Inc. | 8 | $139 |
| Xeris Pharmaceuticals, Inc. | 6 | $131 |
| Biogen | 4 | $81 |
| Biomarin Pharmaceutical Inc. | 3 | $66 |
| SK Life Science, Inc. | 3 | $64 |
| Sumitomo Pharma America, Inc. | 12 | $64 |
| Tandem Diabetes Care, Inc. | 2 | $49 |
| Sunovion Pharmaceuticals Inc. | 7 | $47 |
| AstraZeneca | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
| EMD Serono, Inc. | 1 | $28 |
| Tolmar, Inc. | 1 | $26 |
| Eton Pharmaceuticals, Inc. | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Intrabio Inc | 1 | $24 |
| PTC Therapeutics, Inc. | 1 | $24 |
| Novo Nordisk | 1 | $22 |
| Pyros Pharmaceuticals, Inc. | 1 | $20 |
| NS Pharma, Inc. | 1 | $16 |
| Ascendis Pharma Endocrinology Inc | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Medtronic | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,171
How this compares
$4,443 in reported general payments places this provider in the 95th percentile of 568 pediatrics providers in Oklahoma.
Other pediatrics in Oklahoma City
- Scott MelsonOklahoma City$11K
- Julie MayOklahoma City$5K
- Brittany FarquharOklahoma City$3K
- Hamed AlbiekOklahoma City$3K
- Branson KesterOklahoma City$3K
- Stephanie GrimOklahoma City$2K
- Diana FarrowOklahoma City$2K
- Robert MooreOklahoma City$2K
- Jordan PopeOklahoma City$2K
- Jennifer CooperOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.